Deann Gavney joined WashU Medicine in 2017 as a clinic administrator in Orthopedic Surgery and transitioned to Neurology as the clinical operations director in 2020. She has a passion for operations management and enjoys the fast-paced and challenging working environment in Neurology. In her role, she has the opportunity to work with the incredible in-clinic […]
The WashU Alumni Association has chosen Mwiza Ushe, MD, MA, as one of this year’s Distinguished Alumni Scholarship Program (DASP) Faculty Honorees. The program recognizes four outstanding WashU Medicine alumni who are current or emeritus faculty members with a four-year, full-tuition scholarship given to a student in their name. “I couldn’t be prouder that Mwiza […]
Congratulations and welcome to our 2025-2026 residency intern class! We are so excited to welcome this diverse and fantastic group of trainees who are among the best of the best. The Adult Neurology cohort will begin its PGY1 Preliminary Medicine year in July 2025 and its PGY2 Neurology training in July 2026. The Pediatric Neurology […]
As aging bodies decline, the brain loses the ability to cleanse itself of waste, a scenario that scientists think could be contributing to neurodegenerative conditions such as Alzheimer’s disease and Parkinson’s disease, among others. Now, researchers at Washington University School of Medicine in St. Louis report they have found a way around that problem by […]
The research led by Washington University in St. Louis involves families that pass down rare gene mutations almost guaranteeing they’ll develop symptoms at the same age their affected relatives did – information that helps scientists tell if treatments are having any effect. The new findings center on a subset of 22 participants who received amyloid-removing […]
An experimental drug appears to reduce the risk of Alzheimer’s-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a study led by the Knight Family Dominantly Inherited Alzheimer Network-Trials Unit (DIAN-TU), which is based at Washington University School of Medicine in St. Louis. The […]
In January, the FDA banned the use of Red Dye No. 3 in foods and drugs because high concentrations of the dye were shown to cause cancer in rats. In this Living Well, First Alert 4’s Taylor Holt sits down with a local doctor to dig into the ban, find out what’s next and what […]
Sarah Bauer Huang, MD, PhD, has been appointed head of the Section of Neonatal Neurology, effective July 1, 2025. Chris Smyser, MD, will step down from this position to focus on his role as associate director of the Division of Pediatric and Developmental Neurology. Smyser joined the faculty at Washington University School of Medicine in […]
A recent safety surveillance paper published in Neurology reported that of eleven pediatric patients who were treated with tenecteplase for suspected stroke, there were no instances of intracranial bleeding or other safety concerns. This study is an important first step toward further research to establish the safety and efficacy of tenecteplase for treating pediatric stroke. […]
Eight years after receiving a life-shattering diagnosis, a New Jersey mother credits an “amazing” new drug for stopping her disease in its tracks. Raziel Green, 52, an active runner and mother of two, was diagnosed with a rare form of ALS in 2017.